AvinashHosanagarMD

PubMed

• Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022.
  Kevin F Boehnke, Rachel Sinclair, Felicia Gordon, Douglas R Roehler, Tristin Smith, Brooke Hoots, Avinash Hosanagar> ;Annals of Internal Medicine. 2024 Apr 1
• Clinical Outcomes of Intravenous Ketamine Treatment for Depression in the VA Health System.
  Gilmer, W., Paul N Pfeiffer, Jamarie Geller, Dara Ganoczy, Jennifer Jagusch, John Carty, Fe Erlita D Festin, William S Gilmer, Brian Martis, Mohini Ranganathan, Ilse R...> ;The Journal of Clinical Psychiatry. 2024 Jan 8
• 2 citations
  Ketamine Use in Child and Adolescent Psychiatry: Emerging Data in Treatment-Resistant Depression, Insights from Adults, and Future Directions.
  Kaitlyn Ryan, Avinash Hosanagar> ;Current Psychiatry Reports. 2023 Aug 1
• Assessment of Outcome-Based Measures of Depression Care Quality in Veterans Health Administration Facilities.
  Paul N Pfeiffer, Kara Zivin, Avinash Hosanagar, Vanessa Panaite, Dara Ganoczy, H Myra Kim, Timothy Hofer, John D Piette> ;The Journal of Behavioral Health Services & Research. 2023 Jan 1
• 18 citations
  U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020 : An Observational Study.
  Kevin F Boehnke, Owen Dean, Rebecca L Haffajee, Avinash Hosanagar> ;Annals of Internal Medicine. 2022 Jul 1
• 8 citations
  The Addictive Potential and Challenges With Use of the "Herbal Supplement" Kratom: A Case Report and Literature Review.
  Akhil Anand, Avinash Hosanagar> ;Pain Medicine. 2021 Apr 3
• 2 citations
  Ketamine's rapid antisuicidal effects are not attenuated by Buprenorphine.
  Avinash Hosanagar, Andrew Schmale, Andrew LeBlanc> ;Journal of Affective Disorders. 2021 Mar 1
• 3 citations
  Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects
  Avinash Hosanagar, Joseph Cusimano, Rajiv Radhakrishnan> ;The Journal of Clinical Psychiatry. 2021 Feb 23
• 1 citations
  Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2: Review of the Evidence.
  Avinash Hosanagar, Joseph Cusimano, Rajiv Radhakrishnan> ;The Journal of Clinical Psychiatry. 2021 Feb 23
• 6 citations
  Drug Misuse in the Veterinary Setting: an Under-recognized Avenue.
  Akhil Anand, Avinash Hosanagar> ;Current Psychiatry Reports. 2021 Jan 6
• 3 citations
  Phenibut Use in a Patient Prescribed Gabapentinoids.
  Carrie M Tamarelli, Avinash Hosanagar> ;Pain Medicine. 2021 Mar 18
• 6 citations
  Gaps in Alcohol Screening and Intervention Practices in Surgical Healthcare: A Qualitative Study.
  Anne C. Fernandez, Timothy C. Guetterman, Brian Borsari, Michael J Mello, Jessica Mellinger, Hanne Tonnesen, Avinash Hosanagar, Arden M. Morris, Frederic C. Blow> ;Journal of Addiction Medicine. 2021 Apr 1
• 1 citations
  Pain moderates changes in psychological flexibility but not substance use symptoms during substance use disorder treatment.
  Katherine T. Foster, Colleen Ehrnstrom, Stephen T. Chermack, Avinash Hosanagar> ;Psychiatry Research. 2016 Nov 30
• 2 citations
  Opioid Overdose: Risk Assessment and Mitigation in Outpatient Treatment.
  Lewei Allison Lin, Avinash Hosanagar, Tae Woo Park, Amy S. B. Bohnert> ;Journal of Addiction Medicine. 2016 Nov 1
• 50 citations
  Understanding Risk Factors for Opioid Overdose in Clinical Populations to Inform Treatment and Policy.
  Tae Woo Park, Lewei Allison Lin, Avinash Hosanagar, Amanda Kogowski, Katie Paige, Amy S.B. Bohnert> ;Journal of Addiction Medicine. 2016 Nov 1
• 93 citations
  Oxytocin modulation of amygdala functional connectivity to fearful faces in generalized social anxiety disorder
  Stephanie M. Gorka, Daniel A. Fitzgerald, Izelle Labuschagne, Avinash Hosanagar, Amanda G. Wood, Pradeep J. Nathan, K. Luan Phan> ;Neuropsychopharmacology. 2015 Jan 1
• 26 citations
  A systematic review of psychological interventions for adult and pediatric patients with vocal cord dysfunction.
  Loveleen Guglani, Sarah Atkinson, Avinash Hosanagar, Lokesh Guglani> ;Frontiers in Pediatrics. 2014 Aug 8
• 141 citations
  Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder.
  Sonam Dodhia, Avinash Hosanagar, Daniel A. Fitzgerald, Izelle Labuschagne, Amanda G. Wood, Pradeep J. Nathan, K. Luan Phan> ;Neuropsychopharmacology. 2014 Jan 1
• 9 citations
  Acute urinary retention secondary to buprenorphine administration.
  Ryan Edwards, Catherine Monica McCormick-Deaton, Avinash Hosanagar> ;The American Journal of Emergency Medicine. 2014 Jan 1
• 28 citations
  Are “Bath Salts” the next generation of stimulant abuse?
  Gerald Scott Winder, Nathan Stern, Avinash Hosanagar> ;Journal of Substance Abuse Treatment. 2013 Jan 1
• 210 citations
  Meta-analysis of functional neuroimaging studies of emotion perception and experience in schizophrenia.
  Stephan F. Taylor, Jian Kang, Inga S. Brege, Ivy F. Tso, Avinash Hosanagar, Timothy D. Johnson> ;Biological Psychiatry. 2012 Jan 15
• 60 citations
  Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: Comparing vulnerability markers
  Vaibhav A. Diwadkar, Dhruman D. Goradia, Avinash Hosanagar, Diana Mermon, Debra M. Montrose, Boris Birmaher, David Axelson, R. Rajarathinem, Luay Haddad, Ali Amirsadri...> ;Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2011 Jul 1
• 38 citations
  Hippocampal volume development in healthy siblings of childhood-onset schizophrenia patients.
  Anand Mattai, Avinash Hosanagar, Brian Weisinger, Deanna Greenstein, Reva Stidd, Liv Clasen, Francois Lalonde, Judith Rapoport, Nitin Gogtay> ;The American Journal of Psychiatry. 2011 Apr 1
• Reply to: Neurobiology of Emotional Dysfunction in Schizophrenia: New Directions Revealed Through Meta-Analyses.
  Taylor, S. F., Kang, J., Brege, I. S., Tso, I. F., Hosanagar, A., Johnson, T. D.> ;Biol Psychiatry. 2011 Dec 27
• Join now to see all